Cargando…
LOXL2 Inhibitors and Breast Cancer Progression
LOX (lysyl oxidase) and lysyl oxidase like-1–4 (LOXL 1–4) are amine oxidases, which catalyze cross-linking reactions of elastin and collagen in the connective tissue. These amine oxidases also allow the cross-link of collagen and elastin in the extracellular matrix of tumors, facilitating the proces...
Autores principales: | Ferreira, Sandra, Saraiva, Nuno, Rijo, Patrícia, Fernandes, Ana S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921998/ https://www.ncbi.nlm.nih.gov/pubmed/33669630 http://dx.doi.org/10.3390/antiox10020312 |
Ejemplares similares
-
Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis
por: Ramos, Sofia, et al.
Publicado: (2022) -
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
por: Chang, Joan, et al.
Publicado: (2017) -
Anti-Migratory and Pro-Apoptotic Properties of Parvifloron D on Triple-Negative Breast Cancer Cells
por: Saraiva, Nuno, et al.
Publicado: (2020) -
LOXL2 in Cancer: A Two-Decade Perspective
por: Cano, Amparo, et al.
Publicado: (2023) -
Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)